,Publication Owner,JIRA Epic #,Base_Project,Status/ImmPort Study ID,Base_Project.1,PMID,PMID_N,PMID_link,Publication_Title,Journal,Author(s),Pub Date,PI,print_type,citation
0,Liu,,CA260517,,CA260517,"35025672, ","PMID_35025672, ","https://pubmed.ncbi.nlm.nih.gov/35025672, ",Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses,Science translational medicine,"Benjamin L Sievers, Saborni Chakraborty, Yong Xue, Terri Gelbart, Joseph C Gonzalez, Arianna G Cassidy, Yarden Golan, Mary Prahl, Stephanie L Gaw, Prabhu S Arunachalam, Catherine A Blish, Scott D Boyd, Mark M Davis, Prasanna Jagannathan, Kari C Nadeau, Bali Pulendran, Upinder Singh, Richard H Scheuermann, Matthew B Frieman, Sanjay Vashee, Taia T Wang, Gene S Tan",,BOYD,,Sci Transl Med. 2022 Mar 2;14(634):eabn7842.
1,Liu,,CA260492,,CA260492,"35061630, ","PMID_35061630, ","https://pubmed.ncbi.nlm.nih.gov/35061630, ",CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses,The Journal of clinical investigation,"Bezawit A Woldemeskel, Arbor G Dykema, Caroline C Garliss, Saphira Cherfils, Kellie N Smith, Joel N Blankson",,KLEIN,,J Clin Invest. 2022 Mar 1;132(5):e156083.
2,Mani,,CA260543,,CA260543,35217407.,PMID_35217407.,https://pubmed.ncbi.nlm.nih.gov/35217407.,Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications,EBioMedicine,"Oisin F McElvaney, Takanori Asakura, Suzanne L Meinig, Jose L Torres-Castillo, Robert S Hagan, Claudie Gabillard, Mark P Murphy, Leigh B Thorne, Alain Borczuk, Emer P Reeves, Ross E Zumwalt, Yu Mikami, Tomas P Carroll, Kenichi Okuda, Grace Hogan, Oliver J McElvaney, Jennifer Clarke, Natalie L McEvoy, Patrick W Mallon, Cormac McCarthy, Ger Curley, Matthew C Wolfgang, Richard C Boucher, Noel G McElvaney",,BARIC,,EBioMedicine. 2022 Feb 22;77:103894.
